Comparison of Characteristics and Outcomes of Trial Participants and Non-participants: Example of Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial.Biol Blood Marrow Transplant.(2015).
Comparison of outcomes of 8/8 and 7/8 allele-matched unrelated BMT and single unit CBT in adults with acute leukemia.Biol Blood Marrow Transplant.(2015).
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).Int J Hematol.(2015).
Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT.Leuk Res47, 47-53.(2016).
Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.Haematologica.(2016).
Additional cytogenetic abnormalities with Philadelphia chromosome-positive acute lymphoblastic leukemia on allogeneic stem cell transplantation in the tyrosine kinase inhibitor era.Biol Blood Marrow Transplant.(2018).
Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.Leuk Res75, 50-57.(2018).
Clinical implications of t(11;14) in patients with multiple myeloma undergoing autologous stem cell transplantation.Biol Blood Marrow Transplant.(2018).
Comparison of HLA allele mismatch and antigen mismatch in unrelated bone marrow transplantation in patients with leukemia.Biol Blood Marrow Transplant.(2018).
Hematopoietic cell transplantation for acute panmyelosis with myelofibrosis: a retrospective study in Japan.Biol Blood Marrow Transplant.(2018).
Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantatio.Br J Haematol.(2019).
Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults.Biol Blood Marrow Transplant.(2019).
Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.Hematol Oncol.(2019).
Comparison of outcomes of allogeneic transplantation for primary myelofibrosis among hematopoietic stem cell source groups.Biol Blood Marrow Transplant.(2019).
Conditioning intensity for allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with poor-prognosis cytogenetics in first complete remission.Biol Blood Marrow Transplant.(2019).
Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.Ann Hematol.(2019).
High dose chemotherapy with autologous stem cell transplantation in primary central nervous system lymphoma: Data from the Japan Society for Hematopoietic Cell Transplantation (JSHCT) registry.Biol Blood Marrow Transplant.(2019).
Impact of high frequency HLA haplotypes on clinical cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.(2019).
Impact of homozygous conserved extended HLA haplotype on single cord blood transplantation: Lessons for induced pluripotent stem cell banking and transplantation in allogeneic settings.Biol Blood Marrow Transplant.(2019).